Projected Income Statement: Exelon Corporation

Forecast Balance Sheet: Exelon Corporation

Forecast Balance Sheet - Exelon Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 41,235 39,077 43,563 46,292 49,454 52,826 56,838 60,476
Change - -5.23% 11.48% 6.26% 6.83% 6.82% 7.59% 6.4%
Announcement Date 2/25/22 2/14/23 2/21/24 2/12/25 2/12/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Exelon Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 7,981 7,147 7,408 7,097 8,529 9,876 10,576 10,657
Change - -10.45% 3.65% -4.2% 20.18% 15.8% 7.09% 0.76%
Free Cash Flow (FCF) 1 -4,969 -2,277 -2,705 -1,528 -2,275 -122 -678 109
Change - 54.18% -18.8% 43.51% -48.89% 94.64% -455.74% 116.08%
Announcement Date 2/25/22 2/14/23 2/21/24 2/12/25 2/12/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Exelon Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 23.55% 34.81% 34.65% 34.36% 36.21% 37.42% 39.21% 40.76%
EBIT Margin (%) 6.94% 17.39% 18.52% 18.76% 21.21% 21.97% 23.03% 24.32%
EBT Margin (%) 6.07% 12.6% 12.44% 11.58% 13.57% 13.57% 14.31% 15.01%
Net margin (%) 4.69% 11.37% 10.71% 10.68% 11.41% 11.4% 12% 12.48%
FCF margin (%) -13.67% -11.94% -12.45% -6.64% -9.38% -0.48% -2.58% 0.4%
FCF / Net Income (%) -291.27% -104.93% -116.19% -62.11% -82.19% -4.2% -21.49% 3.2%

Profitability

        
ROA 2.11% 1.9% 2.36% 2.35% 2.47% 2.44% 2.52% 2.61%
ROE 8.25% 7.34% 9.41% 9.34% 9.94% 9.81% 9.91% 10.08%

Financial Health

        
Leverage (Debt/EBITDA) 4.82x 5.88x 5.79x 5.85x 5.63x 5.53x 5.51x 5.43x
Debt / Free cash flow -8.3x -17.16x -16.1x -30.3x -21.74x -433x -83.83x 554.83x

Capital Intensity

        
CAPEX / Current Assets (%) 21.96% 37.46% 34.1% 30.82% 35.16% 38.72% 40.22% 39%
CAPEX / EBITDA (%) 93.26% 107.6% 98.39% 89.69% 97.09% 103.47% 102.59% 95.68%
CAPEX / FCF (%) -160.62% -313.88% -273.86% -464.46% -374.9% -8,095.25% -1,559.96% 9,777.34%

Items per share

        
Cash flow per share 1 3.073 - 4.717 5.552 6.18 6.661 6.724 7.241
Change - - - 17.7% 11.3% 7.79% 0.94% 7.69%
Dividend per Share 1 1.53 1.35 1.44 1.52 1.6 1.682 1.769 1.854
Change - -11.76% 6.67% 5.56% 5.26% 5.13% 5.17% 4.79%
Book Value Per Share 1 35.13 - 25.78 26.84 28.15 29.87 31.35 32.97
Change - - - 4.11% 4.88% 6.12% 4.94% 5.19%
EPS 1 1.74 2.19 2.34 2.45 2.73 2.845 3.04 3.25
Change - 25.86% 6.85% 4.7% 11.43% 4.2% 6.86% 6.92%
Nbr of stocks (in thousands) 978,318 993,742 995,437 1,004,834 1,010,290 1,032,254 1,032,254 1,032,254
Announcement Date 2/25/22 2/14/23 2/21/24 2/12/25 2/12/26 - - -
1USD
Estimates
2026 *2027 *
P/E 15.6x 14.6x
PBR 1.49x 1.42x
EV / Sales 3.87x 3.91x
Yield 3.79% 3.98%

EPS & Dividend

EPS & Dividend - Exelon Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - Exelon Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Exelon Corporation
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Exelon Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
44.43USD
Average target price
48.00USD
Spread / Average Target
+8.04%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Exelon Corporation
  1. Stock Market
  2. Stocks
  3. EXC Stock
  4. E1XC34 Stock
  5. Financials Exelon Corporation